P04 Newborn affected by noxious substances transmitted via placenta or breast milkNon-billable header with 9 child codes.
P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryP04.1 Newborn affected by other maternal medicationP04.2 Newborn affected by maternal use of tobaccoP04.3 Newborn affected by maternal use of alcoholP04.4 Newborn affected by maternal use of drugs of addictionP04.5 Newborn affected by maternal use of nutritional chemical substancesP04.6 Newborn affected by maternal exposure to environmental chemical substancesP04.8 Newborn affected by other maternal noxious substancesP04.9 Newborn affected by maternal noxious substance, unspecifiedP00 Newborn affected by maternal conditions that may be unrelated to present pregnancy ("newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)")Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified ("nonteratogenic effects of substances transmitted via placenta or breast milk (P04.-)")Z77 Other contact with and (suspected) exposures hazardous to health ("newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)")P00 Newborn affected by maternal conditions that may be unrelated to present pregnancy ("newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)")Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified ("nonteratogenic effects of substances transmitted via placenta or breast milk (P04.-)")Z77 Other contact with and (suspected) exposures hazardous to health ("newborn affected by noxious substances transmitted via placenta or breast milk (P04.-)")P04 Newborn affected by noxious substances transmitted via placenta or breast milk (this code)P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryP04.1 Newborn affected by other maternal medicationP04.11 Newborn affected by maternal antineoplastic chemotherapyP04.12 Newborn affected by maternal cytotoxic drugsP04.13 Newborn affected by maternal use of anticonvulsants